Related Experiment Video
Updated: Jul 6, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Consensus document on the management of hyperkalemia
Alberto Ortiz1, Carmen Del Arco Galán2, José Carlos Fernández-García3
1Sociedad Española de Nefrología (S.E.N.), Spain.
Insights
Hyperkalaemia, a common electrolyte imbalance, poses significant health risks. This consensus document provides a unified, updated approach to managing hyperkalaemia, incorporating new drug treatments.
Area of Science:
- Internal Medicine
- Cardiology
- Endocrinology
- Nephrology
- Emergency Medicine
Background:
- Hyperkalaemia is a prevalent electrolyte disorder with serious health implications.
- Management is fragmented across specialties, necessitating a unified approach.
- New drug therapies require updated clinical guidelines.
Purpose of the Study:
- To review fundamental aspects of potassium balance and hyperkalaemia.
- To outline the concept, epidemiology, pathophysiology, and diagnostic strategies.
- To provide updated therapeutic recommendations for hyperkalaemia management.
Main Methods:
- Consensus document developed by leading Spanish scientific societies.
- Comprehensive review of existing evidence and published studies.
- Focus on a multidisciplinary approach to patient care.
Main Results:
- Provides a foundational understanding of potassium homeostasis.
- Details the clinical presentation and underlying mechanisms of hyperkalaemia.
- Offers guidance on current diagnostic and therapeutic interventions.
Conclusions:
- Emphasizes the need for a standardized, multidisciplinary approach to hyperkalaemia.
- Highlights the importance of updated management strategies.
- Aims to serve as a practical tool for clinicians managing hyperkalaemia.
Abstract:
Hyperkalaemia is a common electrolyte imbalance with potentially serious short-, medium- and long-term consequences on morbidity and mortality rates and the use of national health service resources. The fact that different medical specialities can manage hyperkalaemia makes it important to have a unified approach, and the recent availability of new specific drug treatments means that the approach needs to be updated. This consensus document from the scientific societies most directly involved in the management of hyperkalaemia (Sociedad Española de Cardiología [Spanish Society of Cardiology], Sociedad Española de Endocrinología y Nutrición [Spanish Society of Endocrinology and Nutrition], Sociedad Española de Medicina Interna [Spanish Society of Internal Medicine], Sociedad Española de Medicina de Urgencias y Emergencias [Spanish Society of Accident and Emergency Medicine] and Sociedad Española de Nefrología [Spanish Society of Nephrology]) first of all reviews basic aspects of potassium balance and blood potassium. Then it goes on to focus on the concept, epidemiology, pathophysiology and diagnostic and therapeutic approaches to hyperkalaemia. The available evidence and the main published studies have been reviewed with the aim of providing a useful tool in the multidisciplinary approach to patients with hyperkalaemia.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Regulation of Sodium and Potassium
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...

